Xspray Pharm (Q3 update): Two PDUFA dates in 2026 - Redeye

Redeye updates on Xspray following its Q3 report, which featured undramatic financials but offered additional insight into the ongoing regulatory processes. Important newsflow is expected in Q4 regarding both XS003 and Dasynoc, and Xspray is likely heading toward two PDUFA dates by the summer of 2026.

Länk till analysen i sin helhet: https://www.redeye.se/research/1135716/xspray-pharm-q3-update-two-pdufa-dates-in-2026?utm_source=finwire&utm_medium=RSS